PMID- 34552724 OWN - NLM STAT- MEDLINE DCOM- 20210924 LR - 20220426 IS - 2047-2986 (Electronic) IS - 2047-2978 (Print) IS - 2047-2978 (Linking) VI - 11 DP - 2021 TI - A comparative analysis and review of how national guidelines for chronic disease monitoring are made in low- and middle-income compared to high-income countries. PG - 04055 LID - 10.7189/jogh.11.04055 [doi] LID - 04055 AB - BACKGROUND: Understanding how clinical practice guidelines and recommendations are adopted in high-income and low-income settings will help contextualise the value and validity of recommendations in different settings. We investigate how major guidelines and recommendations are developed for management and monitoring of post-diagnosis treatment for three important chronic diseases: HIV, hypertension and type 2 diabetes mellitus (T2DM). METHODS: Eligible guidelines were searched for using PubMed, Google, and health ministry websites for all three conditions. Only guidelines published from 2010 to 2020 were included. The source of the guidelines, year of most recent guideline, and basis of the guidelines were assessed. Additionally, recommendations, the strength of the recommendation and the quality of the evidence for treatment goals of non-pregnant adults and the frequency of monitoring were also extracted and assessed. RESULTS: Of the 42 countries searched 90%, 71% and 60% had T2DM, hypertension and HIV guidelines outlining targets for long-term management, respectively. Most T2DM guidelines recommend an HbA1c target of 1000 copies/mL, with 26%, mostly HICs, defining virological failure as a viral load >200 copies/mL. Recommendations for the frequency of monitoring for any diagnosed patients were available in 18 (55%) of the hypertension guidelines, 25 (93%) of HIV guidelines, and 27 (73%) of the T2DM guidelines. Only a few of the guidelines provide the strength of the recommendation and the quality of the evidence. CONCLUSIONS: Most guidelines from LMICs are adopted or adapted from existing HIC guidelines or international and regional organisation guidelines with little consideration for resource availability, contextual factors, logistical issues and general feasibility. CI - Copyright (c) 2021 by the Journal of Global Health. All rights reserved. FAU - Mukonda, Elton AU - Mukonda E AD - Division of Epidemiology & Biostatistics, School of Public Health & Family Medicine, University of Cape Town, Cape Town, South Africa. FAU - Lesosky, Maia AU - Lesosky M AD - Division of Epidemiology & Biostatistics, School of Public Health & Family Medicine, University of Cape Town, Cape Town, South Africa. LA - eng PT - Journal Article DEP - 20210904 PL - Scotland TA - J Glob Health JT - Journal of global health JID - 101578780 SB - IM MH - Adult MH - Developed Countries MH - *Diabetes Mellitus, Type 2/diagnosis/therapy MH - Humans MH - *Hypertension/diagnosis/therapy MH - Income MH - Viral Load PMC - PMC8442582 COIS- Competing interests: The authors completed the ICMJE Declaration of Interest Form (available upon request from the corresponding author) and declare no conflict of interest. EDAT- 2021/09/24 06:00 MHDA- 2021/09/25 06:00 PMCR- 2021/09/04 CRDT- 2021/09/23 06:51 PHST- 2021/09/23 06:51 [entrez] PHST- 2021/09/24 06:00 [pubmed] PHST- 2021/09/25 06:00 [medline] PHST- 2021/09/04 00:00 [pmc-release] AID - jogh-11-04055 [pii] AID - 10.7189/jogh.11.04055 [doi] PST - epublish SO - J Glob Health. 2021 Sep 4;11:04055. doi: 10.7189/jogh.11.04055. eCollection 2021.